✦ LIBER ✦

964 Association of mitotane to etoposide, adriamycin and cisplatin combination chemotherapy in advanced adrenocortical carcinoma (ACC)

✍ Scribed by A. Berruti; A. Pia; M. Terzolo; C. Letizia; L. Dogliotti; A. Angeli

Book ID: 116167709
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 307 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)96213-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitotane associated with etoposide, doxo

Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma

✍ Alfredo Berruti; Massimo Terzolo; Anna Pia; Alberto Angeli; Luigi Dogliotti 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

BACKGROUND. The use of either mitotane or chemotherapy in the treatment of advanced adrenocortical carcinoma (ACC) has led to scanty and controversial results. The recent finding that mitotane is able to reverse in vitro multidrug resistance has provided a rational basis for combining this agent wit

Phase II evaluation of cisplatin and eto

Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma : A Southwest Oncology Group study

✍ Stephen K. Williamson; Danika Lew; Gary J. Miller; Stanley P. Balcerzak; Laurenc 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Background: A previous southwest oncology group study demonstrated a 30% response rate with the combination of cisplatin and mitotane in the treatment of patients with metastatic adrenocortical carcinoma. several case reports suggested that the combination of etoposide and cisplatin may be an ac

The addition of cisplatin to cyclophosph

The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma : A randomized study of 457 patients

✍ Thierry Urban; Claude Chastang; François-Xavier Lebas; Jean-Paul Duhamel; Guy Ad 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## BACKGROUND. To assess whether the addition of cisplatin (100 mg/m 2 administered intravenously on Day 1) to CDE (cyclophosphamide [1000 mg/m 2 on Day 1], doxorubicin [45 mg/m 2 on Day 1], and etoposide [150 mg/m 2 on Days 1 and 2] combination is useful in the treatment of patients with small cel